Title

Disease-Modifying Therapies For Adults With Multiple Sclerosis

Authoring Organization

Publication Month/Year

April 1, 2018

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

To review evidence on starting, switching, and stopping disease-modifying therapies (DMTs) for multiple sclerosis (MS) in people with clinically isolated syndrome (CIS), relapsingremitting MS (RRMS), and progressive forms of MS; and to develop recommendations for starting, switching, and stopping DMTs

Inclusion Criteria

Female, Male, Adult, Older adult

Health Care Settings

Ambulatory, Hospital, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Treatment

Diseases/Conditions (MeSH)

D009103 - Multiple Sclerosis, D020278 - Demyelinating Autoimmune Diseases, CNS

Keywords

multiple sclerosis (MS), multiple sclerosis, neuromyelitis optica, demyelinating autoimmune diseases, multiple_sclerosis